Akebia Therapeutics, Inc. (AKBA)

1.345 -0.02 (-1.10%) USD  |  NASDAQ  |  Jan 20, 16:00
1.33 -0.02 (-1.12%) After-Hours: 20:00
More

Akebia Therapeutics Normalized Income (Quarterly)

Normalized Income (Quarterly) Chart

View Normalized Income (Quarterly) for AKBA.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Normalized Income (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Normalized Income (Quarterly) Range, Past 5 Years

View Normalized Income (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Normalized Income (Quarterly) Benchmarks

View Normalized Income (Quarterly) Benchmarks
Start Trial
Amgen, Inc. Upgrade
Pfizer Inc. Upgrade
Theravance Biopharma, Inc. Upgrade
Zevra Therapeutics, Inc. Upgrade
Organon & Co. Upgrade